Prenosis Aggregating Patient Biomarker, Clinical Data  to Build a Better Sepsis Diagnostic–360Dx

360Dx, a leading publication focused on the clinical diagnostics industry, profiled Prenosis in its latest feature. The article explores how Prenosis is advancing precision medicine through its Sepsis ImmunoScore™, and its groundbreaking Immunix™ platform. 360Dx covers cutting-edge technologies and developments shaping diagnostics, making this feature a testament to Prenosis’ impact on healthcare innovation.

The article (subscription req’d) can be found here.